← Home
/
CytomX Therapeutics, Inc. (CTMX)
Stock Analysis
CytomX Therapeutics, Inc. (CTMX)
CTMX
CTMX · Market data
2.94
-0.68%
Updated: 2026-06-18 17:28 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
✓
Fundamentals
Weak / Negative
✓
Price Structure
Vulnerable
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
—
↗
Break Above
Confirmation improves above resistance.
3.68
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving CTMX?
📈 Technical recovery is improving
Momentum is Neutral. Watch 3.68 for confirmation and — for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 2.85 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
◎
How to read this setup
From a roadmap perspective, the setup is boxed by support near 2.85 and resistance around 3.68. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
📈 Net Income
-18.25M
↘ Negative
CytomX Therapeutics, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.